Cebranopadol hemicitrate

N/A

Report date: 2025/05/06 16:25:18
NME

Base Information

Drug NameCebranopadol hemicitrate
Drug Alias Name西博帕多cebranopadolcebranopadolum塞雷帕多GRT-6005 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMu opioid receptor agonistsNociceptin receptor agonists
TargetsNociceptin receptorMu opioid receptor
Therapy Area/IndicationsSubstance-Related DisordersChronic PainLow Back Pain +[12] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumBulgariaCanada +[21] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesGrunenthal Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesTris Pharma Inc
Inactive CompaniesN/A
Active IndicationsSubstance-Related DisordersLow Back PainAcute Pain +[5] 
Inactive IndicationsChronic PainPain, PostoperativeDiabetes Mellitus +[7] 

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG